The Wiskott-Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation

Front Immunol. 2023 Jun 7:14:1188099. doi: 10.3389/fimmu.2023.1188099. eCollection 2023.

Abstract

The Wiskott-Aldrich syndrome (WAS) is an X-linked primary immune deficiency caused by a mutation in the WAS gene. This leads to altered or absent WAS protein (WASp) expression and function resulting in thrombocytopenia, eczema, recurrent infections, and autoimmunity. In T cells, WASp is required for immune synapse formation. Patients with WAS show reduced numbers of peripheral blood T lymphocytes and an altered T-cell receptor repertoire. In vitro, their peripheral T cells show decreased proliferation and cytokine production upon aCD3/aCD28 stimulation. It is unclear whether these T-cell defects are acquired during peripheral activation or are, in part, generated during thymic development. Here, we assessed the role of WASp during T-cell differentiation using artificial thymic organoid cultures and in the thymus of humanized mice. Although CRISPR/Cas9 WAS knockout hematopoietic stem and progenitor cells (HSPCs) rearranged the T-cell receptor and differentiated to T-cell receptor (TCR)+ CD4+ CD8+ double-positive (DP) cells similar to wild-type HSPCs, a partial defect in the generation of CD8 single-positive (SP) cells was observed, suggesting that WASp is involved in their positive selection. TCR repertoire analysis of the DP and CD8+ SP population, however, showed a polyclonal repertoire with no bias toward autoreactivity. To our knowledge, this is the first study of the role of WASp in human T-cell differentiation and on TCR repertoire generation.

Keywords: ATO; CRISPR/Cas9; INDEL; T-cell development; T-cell repertoire; Wiskott Aldrich syndrome; primary immunodeficiencies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Lineage
  • Humans
  • Mice
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Antigen, T-Cell / metabolism
  • Wiskott-Aldrich Syndrome Protein* / metabolism
  • Wiskott-Aldrich Syndrome*

Substances

  • Wiskott-Aldrich Syndrome Protein
  • Receptors, Antigen, T-Cell

Grants and funding

This research was supported by grants from the Research Foundation – Flanders (FWO), including G036717N (BV) and 1S14318N (MP) and by a WELBIO grant (WELBIO-CR-2022 A – 15, DV). GSS is supported by Télévie-FNRS (grant 7.4586.19 and 922 7.6529.21).